top of page

Latest News

17.12.25

Introduction to the Hypermarker Randomised Clinical Trial

Hypermarker aims to personalise hypertension treatment through metabolomics

Read More
Introduction to the Hypermarker Randomised Clinical Trial

29.10.25

New insights from the Hypermarker team

New interview series released on our YouTube channel

Read More
New insights from the Hypermarker team

10.7.25

Hypermarker clinical trial design finalised with patient input

Trial to launch in four countries with strong focus on patient-informed design

Read More
Hypermarker clinical trial design finalised with patient input

12.6.25

Hypermarker partners with Uppsala University

Metabolic profiling of PHYSIC trial samples marks a new step toward personalised hypertension treatment

Read More
Hypermarker partners with Uppsala University

15.5.25

Consortium gathers in Birmingham for the 2025 Hypermarker annual meeting

Two days of collaboration, patient involvement, and strategic planning for the next phase

Read More
Consortium gathers in Birmingham for the 2025 Hypermarker annual meeting

Contact Information

 

For more details regarding the Hypermarker project, please reach out to Carl Steinbeisser via email or stay updated by following us on our social media platforms.

​

Email: carl [at] collaborate [dot] eu

EN_FundedbytheEU_RGB_POS.png
UKRI Logo

Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Health and Digital Executive Agency (HaDEA). Neither the European Union nor the granting authority can be held responsible for them.

​

This work is also supported by the UKRI Horizon Europe Guarantee scheme.

  • LinkedIn
  • Youtube
Terms of use
Privacy

© 2025 by Collaborate Project Management GmbH. 

bottom of page